Blockade of B cell‐activating factors attenuates DSS‐induced chronic colitis by inhibiting NF‐κB activation.[36] Similarly, gut relief attenuates dextran sulfate sodium‐induced colitis by inhibiting NF‐κB signaling in mice.[37]. This evidence concerns the gene NFKB1 and colitis.